FLUZONE Quadrivalent
Sanofi Pasteur Product Monograph 450/477 - FLUZONE Quadrivalent Page 1 of 35 PRODUCT MONOGRAPH FLUZONE Quadrivalent Influenza Virus Vaccine Quadrivalent Types A and B (Split Virion) Suspension for Injection Active Immunizing Agent for the Prevention of Influenza ATC Code: J07B B Manufactured by: Sanofi Pasteur Limited Toronto, Ontario, Canada Fabricated by: Sanofi Pasteur Inc. Swiftwater, PA 18370 USA Control #: 238593 Date of Approval: April 29, 2020 Sanofi Pasteur Product Monograph 450/477 - FLUZONE Quadrivalent Page 2 of 35 Table of Contents PART I: HEALTH PROFESSIONAL INFORMATION ........................................ ................... 4 SUMMARY PRODUCT INFORMATION ........................................ ........................................ ...... 4 DESCRIPTION.
age, 190 adults ≥18 years of age, and 225 adults ≥65 years of age). (6) (7) (8) For children requiring a second dose as per the U.S. ACIP guidelines, the doses were administered approximately 4 weeks apart. The most common injection-site reaction in children and adults occurring after vaccine administration was pain.
Download FLUZONE Quadrivalent
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: